Global Industry News

Why Are Pharmaceutical Companies Using Microfiltration Membranes?

Wastewater treatment has become quintessential in recent times as environmental degradation caused by inadequate or no wastewater management poses a substantial threat to economic activity and human and animal health. With the surging awareness regarding the potential threats of inadequate wastewater treatment, countries across the world are adopting microfiltration technologies. Water treatment plants are increasingly opting for microfiltration membranes due to their proven economic efficiency and high performance.

Moreover, the growing pharmaceutical industry will help the microfiltration membrane market witness a CAGR of 9% during the forecast period (2020–2030). According to P&S Intelligence, the market generated revenue of $2,885.57 million in 2019, and it is projected to generate $7,517.38 million revenue by 2030. Pharmaceutical companies are extensively using polypropylene (PP), polyethersulfone (PES), and polyvinylidene fluoride (PVDF) microfiltration membranes for the filtration of proteins and preservatives, due to their exceptional retention characteristics, high flow rate, and low protein binding feature.

The type segment of the microfiltration membrane market is classified into cellulose, polyimide, PP, PES, PVDF, polyether ether ketone (PEEK), and polytetrafluoroethylene (PTFE). Among these, the PVDF category held the largest market share in 2019 due to the ability of PVDF microfiltration membranes to offer high flow rates for solvent-based and mobile phase applications, such as multiplexed bead-based assays and sample preparation. Owing to these advantages, a huge quantity of such membranes is being used in the pharmaceutical industry for protein separation.

Globally, the Asia-Pacific microfiltration membrane market generated the highest revenue in 2019 due to the rising stringency of the regulatory standards, augmenting need for wastewater treatment, and increasing need for desalination to counter the water shortage in China, the Philippines, India, and Thailand. Besides, the soaring number of manufacturing facilities and research centers of various pharmaceutical and biotechnology companies in the region will support the APAC market growth at the highest CAGR during the forecast period.

Therefore, the booming demand for treated water and growing consumption of uncontaminated and unadulterated food and drinks will augment the usage of microfiltration membranes in the foreseeable future.

Share:

No comments:

Post a Comment

Follow Me

Follow on LinkedIn

Followers

Total Pageviews

Popular Posts

Blog Archive

Recent Posts

Label Cloud